Fresh analysis indicates that patients who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who halt conventional lifestyle programs.
Published data in a prominent medical journal shows that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"People buying such medications should be aware of the potential of rapid weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment mass within about 18 months.
Comparing Treatments
The study, which looked at dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with older methods.
The team emphasize that people who shed pounds through diet and exercise generally have a less rapid creep back—around 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Nutrition scientists suggest the mode of action of the injections is key to understanding the amplified regain.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of GLP-1 concentrations several times higher than normal might result in the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is unsuppressed, making binge eating far more likely."
A Lifelong Condition?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals say that, considering the high risk of weight regain, the therapy should be considered life-long.
This perspective is supported by pharmaceutical companies, who say that the findings "highlight the chronic character of excess weight," comparing it to managing conditions like high blood pressure.
Patient Testimonies
Users who have come off the jabs explain a intense resurgence of hunger.
"I experienced a switch that goes on and you're instantly ravenous," said one woman.
This challenge is worsened if users have not established lasting dietary or behavioural changes during treatment.
Widespread Adoption
Recent estimates suggest that a significant number of people in the UK have used these injections in the last 12 months, with interest remaining high.
- Use is greater among females compared to men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Finally, researchers caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a standalone solution and long-term success hinges on ongoing lifestyle support.
